Inquilinus limosus in patients with cystic fibrosis, Germany.
We identified Inquilinus limosus, a recently described ?-proteobacterium, in sputum of 2 patients with cystic fibrosis whose respiratory tracts were persistently colonized for >9 months. We present data on the epidemiology, antimicrobial susceptibility, and molecular characteristics of I. limosus.
Wellinghausen
Nele
N
Department of Medical Microbiology and Hygiene, University of Ulm, Robert-Koch-Str. 8, D-89081, Ulm, Germany. nele.wellinghausen@medizin.uni-ulm.de
Essig
Andreas
A
Sommerburg
Olaf
O
D000293:Adolescent; D020561:Alphaproteobacteria / Q000187:drug effects / Q000302:isolation & purification*; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003550:Cystic Fibrosis / Q000382:microbiology*; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents